Picton Mahoney Asset Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,423
| Closed | -$35K | – | 982 |
|
|
2024
Q4 | $35K | Buy |
6,423
+3,581
| +126% | +$19.5K | ﹤0.01% | 388 |
|
|
2024
Q3 | $21K | Buy |
+2,842
| New | +$21K | ﹤0.01% | 450 |
|
|
2020
Q1 | – | Sell |
-4,920
| Closed | -$355K | – | 328 |
|
|
2019
Q4 | $355K | Sell |
4,920
-14,436
| -75% | -$1.04M | 0.02% | 188 |
|
|
2019
Q3 | $2.72M | Buy |
19,356
+2,370
| +14% | +$333K | 0.19% | 100 |
|
|
2019
Q2 | $3.11M | Sell |
16,986
-119
| -0.7% | -$21.8K | 0.21% | 92 |
|
|
2019
Q1 | $2.72M | Buy |
+17,105
| New | +$2.72M | 0.21% | 93 |
|
|
2018
Q1 | – | Sell |
-16,200
| Closed | -$2.67M | – | 216 |
|
|
2017
Q4 | $2.67M | Sell |
16,200
-69,900
| -81% | -$11.5M | 0.19% | 106 |
|
|
2017
Q3 | $5.36M | Sell |
86,100
-9,655
| -10% | -$602K | 0.4% | 75 |
|
|
2017
Q2 | $7.63M | Sell |
95,755
-27,300
| -22% | -$2.18M | 0.54% | 70 |
|
|
2017
Q1 | $8.74M | Buy |
123,055
+10,400
| +9% | +$739K | 0.59% | 62 |
|
|
2016
Q4 | $5.75M | Buy |
112,655
+77,255
| +218% | +$3.95M | 0.47% | 76 |
|
|
2016
Q3 | $1.63M | Sell |
35,400
-16,600
| -32% | -$764K | 0.11% | 135 |
|
|
2016
Q2 | $1.57M | Sell |
52,000
-1,300
| -2% | -$39.2K | 0.1% | 143 |
|
|
2016
Q1 | $1.71M | Sell |
53,300
-3,800
| -7% | -$122K | 0.11% | 136 |
|
|
2015
Q4 | $3.33M | Sell |
57,100
-19,800
| -26% | -$1.15M | 0.2% | 106 |
|
|
2015
Q3 | $3.25M | Buy |
76,900
+39,400
| +105% | +$1.67M | 0.19% | 107 |
|
|
2015
Q2 | $2.74M | Buy |
+37,500
| New | +$2.74M | 0.14% | 115 |
|